By Associate Professor Anthony Michael Joshua

Journal articles

Alibhai SMH; Manokumar T; Aziz S; Rizvi F; Breunis H; Joshua AM, 2015, 'Does frailty affect response to chemotherapy in older men with metastatic castration-resistant prostate cancer?', Journal of Clinical Oncology, 33, pp. e20528 - e20528, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.e20528

Beer TM; Armstrong AJ; Sternberg CN; Higano CS; Rathkopf DE; Loriot Y; Saad F; Joshua AM; De Bono JS; Venner PM; Carles J; Mainwaring PN; Evans CP; Parli T; Mansbach HH; Bhattacharya S; Van Os S; Phung D; TOMBAL BF, 2015, 'Enzalutamide (ENZA) in men with chemotherapy-Naïve metastatic castration-resistant prostate cancer (mCRPC): Final analysis of the phase 3 PREVAIL study.', Journal of Clinical Oncology, 33, pp. 5036 - 5036, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.5036

Daud A; Ribas A; Robert C; Hodi FS; Wolchok JD; Joshua AM; Hwu W-J; Weber JS; Gangadhar TC; Joseph RW; Dronca RS; Patnaik A; Zarour HM; Kefford R; Lindia JA; Li XN; Ebbinghaus S; Kang SP; Hamid O, 2015, 'Long-term efficacy of pembrolizumab (pembro; MK-3475) in a pooled analysis of 655 patients (pts) with advanced melanoma (MEL) enrolled in KEYNOTE-001.', Journal of Clinical Oncology, 33, pp. 9005 - 9005, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.9005

Kibiro M; Khoja L; Hogg D; Butler MO; Metser U; Atenafu EG; Joshua AM, 2015, 'Patterns of response to anti-PD1 treatment: Comparison of three radiological response criteria and effect on overall survival (OS) in metastatic melanoma patients (MM).', Journal of Clinical Oncology, 33, pp. 9073 - 9073, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.9073

Leibowitz-Amit R; Khoja L; Tannock IF; Joshua AM, 2015, 'Choosing a better end point for trials of bone-protective agents', Annals of Oncology, 26, pp. 1032 - 1033, http://dx.doi.org/10.1093/annonc/mdv039

Sridhar SS; Joshua AM; Gregg R; Booth CM; Murray N; Golubovic J; Wang L; Harris P; Chi KN, 2015, 'A phase II study of GW786034 (Pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancer', Clinical Genitourinary Cancer, 13, pp. 124 - 129, http://dx.doi.org/10.1016/j.clgc.2014.06.001

Attard G; De Bono JS; Logothetis CJ; Fizazi K; Mukherjee SD; Joshua AM; Schrijvers D; Van Den Eertwegh AJM; Li W; Molina A; Griffin TW; Kheoh T; Ricci DS; Zelinsky K; Rathkopf DE; Scher HI; Ryan CJ, 2015, 'Improvements in radiographic progression-free survival stratified by ERG gene status in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate', Clinical Cancer Research, 21, pp. 1621 - 1627, http://dx.doi.org/10.1158/1078-0432.CCR-14-1961

Tan Q; Joshua AM; Saggar JK; Yu M; Wang M; Kanga N; Zhang JY; Chen X; Wouters BG; Tannock IF, 2015, 'Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy', British Journal of Cancer, 112, pp. 832 - 840, http://dx.doi.org/10.1038/bjc.2015.17

Azad AA; Eigl BJ; Leibowitz-Amit R; Lester R; Kollmannsberger C; Murray N; Clayton R; Heng DYC; Joshua AM; Chi KN, 2015, 'Outcomes with abiraterone acetate in metastatic castration-resistant prostate cancer patients who have poor performance status', European Urology, 67, pp. 441 - 447, http://dx.doi.org/10.1016/j.eururo.2014.01.030

Ryan CJ; Smith MR; Fizazi K; Saad F; Mulders PFA; Sternberg CN; Miller K; Logothetis CJ; Shore ND; Small EJ; Carles J; Flaig TW; Taplin ME; Higano CS; de Souza P; de Bono JS; Griffin TW; De Porre P; Yu MK; Park YC; Li J; Kheoh T; Naini V; Molina A; Rathkopf DE, 2015, 'Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): Final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study', The Lancet Oncology, 16, pp. 152 - 160, http://dx.doi.org/10.1016/S1470-2045(14)71205-7

Leibowitz-Amit R; Templeton AJ; Alibhai SM; Knox JJ; Sridhar SS; Tannock IF; Joshua AM, 2015, 'Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancer', Journal of Geriatric Oncology, 6, pp. 23 - 28, http://dx.doi.org/10.1016/j.jgo.2014.09.183

Manusow JS; Khoja L; Pesin N; Joshua AM; Mandelcorn ED, 2015, 'Retinal vasculitis and ocular vitreous metastasis following complete response to PD-1 inhibition in a patient with metastatic cutaneous melanoma', Journal for ImmunoTherapy of Cancer, 2, http://dx.doi.org/10.1186/s40425-014-0041-1

Power NE; Willie C; Mazzola CR; Tailly T; Sonke E; Pardhan S; Tram A; Brugarolas J; Sener A; Chambers AF; Pautler SE; Leong H; Punjani N; Power NE; Vanhie J; Winquist E; Siemens DR; William M; Wei X; Peng P; Booth CM; Gakis G; Morgan T; Daneshmand S; Keegan K; Clayman R; Mischinger J; Zaid H; Hrbacek J; Ali-El-Dein B; Galland S; Olugbade K; Rink M; Fritsche H-M; Burger M; Chang S; Babjuk M; Thalmann G; Stenzl A; Efstathiou J; Nayak JG; Patel P; Saarela O; Liu Z; Kapoor A; Tanguay S; Finelli A; Rendon RA; Moore R; Breau RH; Kawakami J; Black PC; Drachenberg DE; Matta R; Al Matar A; Bhindi B; Zlotta A; Fleshner N; Jewett M; Hamilton RJ; Finelli A; Kulkarni GS; Lee JK; Sjoberg DD; Thong A; Mulhall JP; Sandhu J; Vickers AJ; Ehdaie B; Elkoushy M; Elshal A; Elhiali M; Azizi M; Hai MA; Gonzalez RR; Eure GR; Kriteman LS; Hueber P-A; Alenizi AM; Bienz M; El Hosni K; Meskawi M; Zorn KC; Radomski S; De Ridder D; Sussman D; Sand P; Sievert K-D; Chapple CR; Nicandro JP; Zhou J; Nitti V; Maciejewski C; Haines T; Rourke KF; Zappavigna CJ; Herschorn S; Braga LH; D’Cruz J; Jegatheeswaran K; DeMaria JE; Lorenzo A; Salle JLP; Kim S; Dave S; Liu K; Mamut A; Shariff S; Braga LH; D’Cruz J; Farrokhyar F; Rickard M; DeMaria JE; Lorenzo A; Hueber P-A; Abdo A; Franc-Guimond J; Barrieras JD; Houle A-M; Koyle M; Lorenzo A; Farhat WA; Beamish T; Gainey S; Rowed S; Odeh R; Alyami F; Koyle M; Farhat WA; Rocha J; Aprikian A; Vanhuyse M; Cury F; Kassouf W; Dragomir A; Hamilton RJ; Ding K; Crook J; O’Callaghan CJ; Higano CS; Dearnaley D; Horwitz E; Goldenberg SL; Gospodarowicz M; Klotz L; Violette P; Agoritsas T; Riikonen J; Santti H; Alexander P; Agarwal A; Bhatnagar N; Dahm P; Montori V; Guyatt GH; Kari TAO; Richard P; Alibhai SM; Urbach D; Fleshner N; Tamilshina N; Klotz L; Finelli A; Savdie R; Aning J; So A; Black PC; Gleave M; Goldenberg SL; Da Silva VC; Cagiannos I; Mallick R; Witiuk K; Cnossen S; Fergusson D; Morash C; Breau RH; Siemens DR; Heidenreich A; Klotz L; Villers A; van Os S; Phung D; Wang F; Bhattacharya S; Chowdhury S; Shore N; Noureldin Y; Elkoushy M; Andonian S; Knudsen BE; Miller NL; Yong C; Wang A; Charchenko C; Humphreys MR; Krambeck AE; Chew BH; Brotherhood HL; Sur RL; Penniston KL; Antonelli JA; Averch TD; Chew BH; Pais VM; Viprakasit DP; Sur RL; Bird VG; Nakada SY; Roberts G; Leslie RJ; Robb S; Beiko DT; Streeper NM; Lim AH; Best SL; Penniston KL; Nakada SY; Olvera-Posada D; Alenezi H; Tailly T; Violette P; Pautler SE; Denstedt J; Razvi H; Cristea OM; Stokl A; Montroy J; Cnossen S; Mallick R; Cagiannos I; Morash C; Breau RH; Billia M; Pahernik S; Relle J; Burtnyk M; Röthke M; Hafron J; Schlemmer H-P; Chin LKJ; Ghai S; Finelli A; McCluskey S; Hlasny E; Corr K; Nesbitt M; Van der Kwast T; Kucharczyk W; Zlotta A; Trachtenberg J; Cerantola Y; Haberer E; Torres J; Alameldin M; Aronson S; Levental M; Bladou F; Anidjar M; Dragomir A; Cerantola Y; Tanguay S; Bladou F; Aprikian A; Kassouf W; Alenizi AM; Valdivieso R; Rajih E; Meskawi M; Taorta C; Bienz M; Hueber P-A; Lavigueur-Blouin H; Trudeau V; El-Hakim A; Zorn KC; Gevariya NR; Bergeron A; Besançon M; Picard V; Leger C; Fradet Y; Al Esawi A; Fradet V; O’Malley PG; Al Hussein Al Awamlh B; Sarkisian AM; Jin S; Nguyen DP; Lee R; Scherr DS; Barbieri CE; Herman M; Toarta C; Bienz M; Trudeau V; Alesawi A; Valdivieso R; Hueber P-A; Alenizi AM; Trinh Q-D; El-Hakim A; Zorn KC; Wallis CJ; Mahar A; Cheung P; Herschorn S; Klotz L; Al-Matar A; Kulkarni GS; Lee Y; Kodama RT; Narod SA; Nam RK; Dason SR; Allard CB; Shayegan B; Alkasab T; Hamilton RJ; Kulkarni GS; Finelli A; Zlotta A; Jewett M; Fleshner N; Bjazevic J; Kaler K; Rittberg R; Saranchuk JW; Drachenberg DE; Boehm K; Meskawi M; Valdivieso R; Larcher A; Sun M; Graefen M; Saad F; Parent M-É; Karakiewicz PI; Liberman D; Jarosek SL; Virnig BA; Elliott SP; Saad F; Ivanescu C; Phung D; Loriot Y; Mansbach H; Beer TM; Tombal B; Holmstrom S; Timilshina N; Alibhai S; Ouellet V; Delvoye N; Drachenberg DE; Finelli A; Jammal M-P; Lapointe H; Li K; Lynch K; Mes-Masson A-M; Paradis JB; Sitarik P; So A; Sutcliffe S; Saad F; Fitch M; Pang K; Ouellet V; Mes-Masson A-M; Chevalier S; Drachenberg DE; Finelli A; Hamel L; Li K; Palmer M; Sitarik P; Sutcliffe S; So A; Tanguay S; Saad F; Akhter W; Khan MJMJ; Moghul M; Karim OO; Laniado MM; Ray AA; Foell KA; Hartsburg CJ; Zadra J; Iocca AJ; Marzouk K; Whelan TF; Hasan T; McBriarty H; Webster TM; Newell K; Wang Y; Hoogenes J; Wu CH; Shayegan B; Alkasab T; Hamilton RJ; Kulkarni GS; Finelli A; Zlotta A; Jewett M; Fleshner N; Rediger C; Bella A; Flannigan R; Bieniek J; Mullen B; Grober ED; Lo K; Jarvi K; Flannigan R; Bieniek J; Jarvi K; Grober ED; Lo K; Mullen B; Singh HHK; Baverstock R; Weber BA; Carlson K; Liberman D; Broghammer J; Smith TG; Voelzke BB; Erickson BA; McClung C; Alsikafi N; Vanni A; Myers J; Elliott SP; Liberman D; Pagliara T; Myers J; Stoffel JT; Elliott SP; Zappavigna CJ; Herschorn S; Zappavigna CJ; Herschorn S; Feldman R; Denes BS; Shultz T; Millar A; Elterman DS; Jarvi K; Elterman DS; Millar A; Jarvi K; Forbes EC; Rourke KF; Shahrour W; Joshi P; Hunter CB; Batra V; Suranah S; Kulkarni S; Rourke KF; Kinnaird A; Chapman D; Haines T; Rourke KF; Wong N; Allard CB; Davies TO; Hoy NY; Rourke KF; Tran H; Flannigan R; Rapoport D; Telb M; Shabana W; Dawod T; Shahin A; Eladl M; Shabana W; Dawod T; Telb M; Shahin A; Eladl M; Alenizi AM; Bienz M; Rajih E; Al-Hathal N; Zorn KC; El-Hakim A; Alenizi AM; Bienz M; Rajih E; Alesawi A; Al-Hathal N; Benayoun S; Lebeau T; Zorn KC; El-Hakim A; Chew BH; Flannigan R; Kurtz MP; Arsovska O; Paterson RF; Eisner B; Lange D; Noureldin Y; Elkoushy M; Andonian S; Noureldin Y; Elkoushy M; Andonian S; Soueidan M; Susan JB; Noureldin Y; Ross EA; Andonian S; Kroczak TJ; Kaler K; Patel P; Al Essawi T; Brodie A; Moghul M; Akhter W; Kalsi J; Tailly T; Larish Y; Nadeau BR; Olvera-Posada D; Alenezi H; Violette P; Glickman L; Amann J; Denstedt J; Razvi H; Alzahrani TM; Ghiculete D; Pace KT; Lee JY; Honey RJD; Alzahrani TM; Ghiculete D; Garbens A; Pace KT; Honey RJD; Alzahrani TM; Ghiculete D; Pace KT; Honey RJD; Kokorovic A; Fuoco MB; Wilson JW; Beiko DT; Althunayan AM; Barrett KP; Honey RJD; Althunayan AM; Ghiculete D; Lee JY; Ordon MH; Honey RJD; Pace KT; Barrett KP; Ghiculete D; Ordon MH; Lee JY; Pace KT; Honey RJD; Barrett KP; Honey RJD; Barrett KP; Ghiculete D; Ordon MH; Lee JY; Pace KT; Honey RJD; Akerman JP; Tu HYV; Hoogenes J; Lambe SA; Matsumoto ED; Chaparala H; Mohamed O; Monga M; Sivalingam S; Kartha GK; Chaparalla H; Calle JC; Monga M; Sivalingam S; Tu HYV; Matsumoto ED; Chew BH; Harriman DI; Lange D; Arsovska O; McDougall E; Paterson RF; Chew BH; McLaughlin PD; Paterson RF; McDougall E; Nugent J; Rowley VA; Buckley J; Zwirewich C; Dawod T; Shabana W; Telb M; Shahin A; Eladl M; Shabana W; Dawod T; Telb M; Shahin A; Eladl M; Patel P; Kaler K; Pruthi D; Kirkpatrick I; Radulovic D; McGregor TB; Alomar l. MA; Tawhary M; Alomar A; Mohammad A; Alenezi H; Nott L; Olvera-Posada D; Tailly T; Pautler SE; Razvi H; Denstedt J; Mittal AA; Tandon SS; Singla SS; Tandon CC; Pruthi D; Chhibba R; Drachenberg DE; McGregor TB; Pruthi D; Liu V; Chhibba R; Gibson I; McGregor TB; Bhatt J; Avery J; Basiuk J; Laupacis A; Cowan K; Weller A; Al Asaaed S; Canil C; Jewett M; Jones J; Allard CB; Kuppermann D; Psutka S; Wu P; Dhyani M; McGovern FJ; McDougal WS; Gervais D; Mueller P; Blute ML; Feldman AS; Lavallee LT; Fitzpatrick RM; Witiuk K; Wood LA; Basiuk J; Vanhuyse M; Tanguay S; Pautler SE; Finelli A; Jewett M; Cagiannos I; Morash C; Breau RH; Richard P; Jewett M; Bhatt J; Evans A; Tamilshina N; Finelli A; Rowe NE; McLarty R; Costello P; McDonald W; Luke PP; Rowe NE; McLarty R; Costello P; McDonald W; Luke PP; Rudzinski JK; Basappa N; Heng DYC; North S; Nayak JG; Patel P; Bjazevic J; Liu Z; Saarela O; Kapoor A; Finelli A; Rendon RA; Tanguay S; Black PC; Breau RH; Kawakami J; Moore R; Drachenberg DE; Dragomir A; Cerantola Y; Kapoor A; Finelli A; Jewett M; Rendon RA; Black PC; Moore R; Kawakami J; Drachenberg DE; Lacombe L; Breau RH; Klotz L; Pautler SE; Lattouf J-B; Aprikian A; Tanguay S; Campbell JD; Luke PP; Trudeau V; Larcher A; Sun M; Boehm K; Meskawi M; Tian Z; Dell’Oglio P; Karakiewicz PI; Trudeau V; Larcher A; Sun M; Boehm K; Dell’Oglio P; Meskawi M; Karakiewicz PI; Trudeau V; Larcher A; Sun M; Meskawi M; Boehm K; Valdivieso R; Tian Z; Karakiewicz PI; Trudeau V; Larcher A; Meskawi M; Valdivieso R; Boehm K; Tian Z; Sun M; Karakiewicz PI; Trudeau V; Larcher A; Fossati N; Tian Z; Popa I; Boehm K; Meskawi M; Valdivieso R; Sun M; Karakiewicz PI; Meskawi M; Valdivieso R; Larcher A; Sun M; Karakiewicz PI; Meskawi M; Valdivieso R; Trudeau V; Sun M; Karakiewicz PI; Aubé M; Bui B; Sabbagh R; Rowe NE; McLarty R; Costello P; McDonald W; Luke PP; Billia M; Mazzola CR; Siddiqui K; Joseph CLK; Ouellet S; Sabbagh R; Carmel M; Jeldres C; Bastiampillai RJ; Lavallee LT; Witiuk K; Mallick R; Fergusson D; Schram D; Morash C; Cagiannos I; Breau RH; Cerantola Y; Ploussard G; Kassouf W; Anidjar M; Bladou F; Pruthi D; Drachenberg DE; Allard CB; Gelpi-Hammerschmidt F; Harshman LC; Faiena I; Modi P; Chung BI; Singer EA; Chang SL; Allard CB; Coret A; Dason SR; Tajzler C; Shayegan B; Matsumoto ED; Kapoor A; Li J; Zhang Q; Pautler SE; Izawa J; Gomez-Lemus J; Leong H; Power NE; Clark RK; Rendon RA; Clark RK; Acker MR; Raha D; Rendon RA; Orabi H; Rousseau A; Bolduc S; Lee JY; Blankstein U; Hoang R; Ordon MH; Pace KT; Lantz AG; Blankstein U; Andrews JM; Honey RJD; Ordon MH; Pace KT; Lee JY; Law J; Rowe NE; Nastis S; Luke PP; McAlpine K; Steele SS; Rourke KF; MacNeily A; Nayak JG; Hartzler A; Izard JP; Dalkin BL; Gore JL; Aboalsamh GA; Lobb I; Saha M; Whiteman M; Luke PP; Sener A; Aboalsamh GA; May M; Archambault J; Sener A; Luke PP; Noureldin Y; Elkoushy M; Andonian S; Farcas MA; Maeve OT; Nasr A; Gerstle JT; Carrillo B; Azzie G; Loeb S; Matta R; Azevedo N; Tong S; Doiron RC; Leveridge MJ; Leveridge MJ; Thangasamy I; Davies B; Finelli A; Stork B; Loeb S; Woo H; Gajewski J; Mason R; Whelan TF; Carlson K; Civitarese A; Yanko D; Desantis D; Crump T; Baverstock R; Patel P; Nayak JG; McGregor TB; Courtemanche K; Chan P; Kassouf W; Abara E; Noushi N; Abara E; Abara E; El-Sherbini M; Abara E; Kanaroglou N; Wehbi E; Rwamasirabo E; Duke L; Sourial M; Ntakiyiruta G; Orabi H; Rousseau A; Morissette A; Bouchard F; Fortin M-C; Bolduc S; Aldousari S; Almarzouq A; Al-Yousef RJ; Abul F; Hussein SA; Thalib L; Natarajan S; Arun N; Kim S; Hoogenes J; Elias R; Kim K; Shayegan B; Piercey KR; Kapoor A; Sonnadara R; Matsumoto ED; Monica VF; Cammisotto P; Campeau L; Monica VF; Cammisotto P; Campeau L; Monica VF; Cammisotto P; Campeau L; Siddiqui K; Billia M; Mazzola CR; Williams A; Al-Zahrani A; Chin LKJ; Stokl A; Cnossen S; Mallick R; Lavallee LT; Morash C; Cagiannos I; Breau RH; Benidir T; Finelli A; Hamilton RJ; Hersey K; Joshua AM; Kulkarni GS; Zlotta A; Fleshner N; Cole-Clark D; Feletto E; Bang A; Chalasani V; Rasiah K; Smith D; Billia M; Siddiqui K; Goodman C; Mazzola CR; Izawa J; Chin LKJ; Billia M; Siddiqui K; Goodman C; Mazzola CR; Williams A; Chin LKJ; Saad F; Shore N; Smith MR; Lipton A; Brown JE; Oudard S; Carducci M; Damiao R; Zhu L; Warner D; Fizazi K; Saad F; Joshua AM; Beer TM; Armstrong A; Sternberg CN; Higano CS; Rathkopf DE; Loriot Y; DeBono J; Carles J; Mainwaring P; Evans CP; Parli T; Mansbach H; Bhattacharya S; Steve VO; Phung D; Tombal B; Venner P; Rocha J; Vanhuyse M; Aprikian A; Cury F; Kassouf W; Dragomir A; Dason SR; Allard CB; Hoogenes J; Orovan W; Shayegan B; Kroczak TJ; Awe JA; Saranchuk JW; Mai S; Drachenberg DE; Kaler K; Rittberg R; Patel P; Kroczak TJ; Saranchuk JW; Drachenberg DE; Bhindi B; Fleshner N; Kulkarni GS; Sutradhar R; Lipscombe L; Jembere N; Saskin R; Alibhai SM; Bhindi B; Hermanns T; Wei Y; Templeton A; Richard P; Bhatt J; Noon A; Jewett M; Hamilton RJ; Trachtenberg J; Finelli A; Fleshner N; Zlotta A; Kulkarni GS; O’Malley PG; Bashir AHAA; Nguyen DP; Wu G; Herman M; Christos P; Sanda MG; Thompson IM; Wei JT; Lee R; Rubin MA; Barbieri CE; Scherr DS; Patel P; Nayak JG; Biljetina Z; Donnelly BJ; Trpkov K; Lateef MA; Péant B; Astolfi M; Kendall-Dupont J; Mes-Masson A-M; Gervais T; Saad F; Huang CH; Bjazevic J; Nayak JG; Quon H; Drachenberg DE; Huang CH; Bjazevic J; Drachenberg DE; Molina OE; LaRue H; Picard V; Têtu B; Nguile-Makao M; Bergeron A; Fradet V; Campos-Lima PO; Lacombe L; Fradet Y; Lavallée E; Ben-Zvi T; Nguile-Makao M; Pelletier J-F; Allaire J; Léger C; Fradet Y; Fradet V; Benidir T; Bhindi B; Kulkarni GS; Finelli A; Hamilton RJ; Jewett M; Hersey K; Theodorus VDK; Evans A; Nesbitt M; Kalnin R; Alibhai S; Trachtenberg J; Fleshner N; Paterson NR; Nguyen LN; Lavallee LT; Witiuk K; Ross J; Mallick R; Shabana W; MacDonald B; Schieda N; Fergusson D; Momoli F; Cnossen S; Cagiannos I; Morash C; Breau RH; Mohammed A; Finelli A; Fleshner N; Winegarden N; Kulkarni GS; Matteliano AA; Kaler K; Drachenberg DE; Saranchuk JW; Alesawi A; Meskawi M; Benayoun S; Lebeau T; El-Hakim A; Alesawi A; Meskawi M; Benayoun S; Lebeau T; El-Hakim A; Marzouk K; Whelan TF; Hasan T; McBriarty H; Zimmermann M; Taussky D; Delouya G; Alenizi AM; Zorn KC; Taussky D; Bahig H; Delouya G; Nadiri A; Bodson-Clermont P; Soulière D; Toren PJ; Allman J; Gleave M; Zoubeidi A; Kang YH; Heo JH; Jin H; Park KC; Kim KH; Hong SJ; Han KS; Duplisea J; Merrimen J; Rendon RA; Feifer AH; Cafazzo J; Seto E; Hu J; Aprikian A; Cury F; Vanhuyse M; Dragomir A; Keefe DT; Flood TA; Breau RH; Cagiannos I; Morash C; Schieda N; Egerdie RB; Tammela T; Sieber P; Lamy O; Ke C; Warner D; Klotz L; Smith MR; Brown JE; Fizazi K; Marx G; Wang H; Warner D; Lipton A; Alhasani H; Salam MJ; Khadermand K; Farhad FK; Anwar A; Dryhurst D; Hammadeh M; Zang A; Ahmed M; Rajih E; Naif AH; Alenizi AM; El-Hakim A; Delouya G; Bahary J-P; Barkati M; Taussky D; Lambert L; Jutras A; Comeau D; Normandeau L; Decamps V; Lattouf J-B; Saad F; Drake MJ; Sokol R; Klaver M; Drogendijk T; Hakimi Z; Odeyemi I; Kerrebroeck V; Philip EV; Drake MJ; Oelke M; Traudtner K; van Charldorp K; Klaver M; Van Kerrebroeck PEV; Hosier GW; Himmelman JG; Tennankore KK; Cox AR; Liberman D; Goldfarb R; Fan Y; Elliott SP; Carlson K; Civitarese A; Weber BA; Crump T; Desantis D; Baverstock R; Wagg AS; Franks B; Ramos B; Berner T; Baverstock R; Civitarese A; Yanko D; Desantis D; Crump T; Carlson K; Azizi M; Hai MA; Gonzalez RR; Eure GR; Kriteman LS; Hueber P-A; Alenizi AM; Bienz M; El Hosni K; Meskawi M; Zorn KC; Tholomier C; Eure GR; Kriteman LS; Hai MA; Gonzalez RR; Zorn KC; Elkoushy M; Elshal A; Elhiali M; Elkoushy M; Elshal A; Elhiali M; Lusty AJ; Siemens DR; Drake MJ; Chapple CR; Oelke M; Drogendijk T; Klaver M; Van Kerrebroeck PEV; Baverstock R; Civitarese A; Weber BA; Desantis D; Crump T; Carlson K; Golda N; Nickel JC; Tripp D; Carr L; Herschorn S; Yassein A; Davies TO; Howlett M; Gibson W; Hunter KF; Chambers T; Wagg AS; Gibson W; Wagg AS; Baverstock R; Civitarese A; Weber BA; Desantis D; Crump T; Carlson K; Elkoushy M; Elshal A; Elhiali M; Lavigueur-Blouin H; Meskawi M; Valdivieso R; Hueber P-A; Trudeau V; Bienz M; Zorn KC; Valdivieso R; Hueber P-A; Meskawi M; Lavigueur-Blouin H; Alenizi AM; Misrai V; Rutman M; Te A; Chungtai B; Barber NJ; Emara AM; Trinh Q-D; Munver R; Zorn KC; Tholomier C; Eure GR; Kriteman LS; Hai MA; Gonzalez RR; Zorn KC; Hueber P-A; Bienz M; Valdivieso R; Misrai V; Rutman M; Te A; Chughtai B; Barber N; Munver R; Zorn KC; Hoy NY; Van Zyl S; St. Martin BA; Agrawal CS; Shah P; Agrawal S; Khanal B; Pandey AK; Shabana W; Dawod T; Telb M; Shahin A; Eladl M; Whoriskey M; Amir B; Cox AR; Quirouet A; Jones S; Bhattacharyya P; Goldman H; Nayak JG; Gore JL; Holt SK; Wright JL; Mossanen M; Dash A; Bhindi B; Hermanns T; Wei Y; Yu J; Templeton A; Noon A; Bhatt J; Richard P; Almatar A; Jewett M; Hamilton RJ; Finelli A; Fleshner N; Zlotta A; Kulkarni GS; Elzayat E; Cagiannos I; Lavallee LT; Cnossen S; Mallick R; Morash C; Breau RH; Siemens DR; MacKillop WJ; Peng Y; Doiron RC; Booth CM; Santos F; Dragomir A; Ahmed AS; Kassouf W; Aprikian A; Bureau M; Rousseau A; Pelletier J; Ringuette-Goulet C; Bernard G; Neveu B; Pouliot F; Bolduc S; Ahmed AS; Santos F; Kassouf W; Tanguay S; Aprikian A; Bos D; Allard CB; Dason SR; Ruzhynsky V; Kapoor A; Shayegan B; Bell M; Yafi FA; Brimo F; Steinberg J; Aprikian A; Tanguay S; Kassouf W; Allaire J; Nguile-Makao M; Léger C; Ben-Zvi T; Fradet Y; Lacombe L; Fradet V; Kinnaird A; Dromparis P; Evans H; Allard M-A; Allaire J; Nguile-Makao M; Léger C; Ben-Zvi T; Fradet Y; Lacombe L; Fradet V; Acker MR; Harb-De la Rosa A; Narayanan G; Manoharan M; Harb-De la Rosa A; Acker MR; Soodana-Prakash N; Balise RR; Parekh D; Manoharan M; Chung J; Kulkarni GS; Matthew A; Guttman D; Fraser I; Bender J; Abdelmutti N; Papadakos J; Jones J; Ben-Zvi T; Allaire J; Allard M-A; Leger C; Nguile-Makao M; Fradet Y; Lacombe L; Fradet V; Neufeld S; Kroczak TJ; Czaykowski P; Koul R; Aljada I; Ahmed S; Drachenberg DE; Nandwani GM; Anwar A; Addla SK; Singh R; Chahal R; Abou-Taleb AA; Noureldin Y; Almatar AA; Matta R; Hermanns T; Wei L; Yu J; Athanasopoulos P; Varghese B; Jewett M; Fleshner N; Zlotta A; Kulkarni GS; O’Malley PG; Al Hussein Al Awamlh B; Nguyen DP; Faltas B; Lee R; Scherr DS; Sanchez A; Rodriguez D; Allard CB; Bechis SK; Cheng J-S; Barrisford GW; Preston MA; Gelpi-Hammerschmidt F; Feldman AS; Nayan M; Jewett M; Anson-Cartwright L; Bedard P; Moore M; Chung P; Warde P; Sweet J; O’Malley M; Hamilton RJ; Nayan M; Jewett M; Bedard P; Hamilton RJ; Ko JJ; Asif T; Li H; Alimohamed N; Bassily D; Nguyen PT; Heng DYC; Punjani N; Power NE; Macleod LC; Nayak JG; Rajanahally S; Holt SK; Schade GR; Lin DW; Gore JL; Nayak JG; Holt SK; Wright JL; Dash A; Gore JL; Beech BB; Izawa J; Pautler SE; Chin LKJ; Power NE; Li J; Willie C; Lowerison M; Pautler SE; Izawa J; Lacefield J; Leong H; Power NE; Siddiqui K; Chan G; Wambolt E; Tangen-Steffin K; Goulart J; Leong H; Leong N; Chin LKJ; Juvet T; Bieniek J; Bachir BG; Margolis M; Grober ED; Lo K; Jarvi K; Abara E; Abara N; Lacroix M; Noushi N; Chiang S; Wu B; Denton R; Cameron R; Liberman D; Jarosek SL; Virnig BA; Elliott SP; Blais A-S; Bergeron M; Nadeau G; Bolduc S; Blais A-S; Nadeau G; Moore K; Genois L; Bolduc S; Keays MA; Snodgrass W; Starke N; Bernstein I; Lee SC; Corbin Bush N; Keays MA; Corbin Bush N; Snodgrass W; Sami S; Dhaliwal N; Fermin Risso C; Cook AJ; Weber BA; Sami S; Frusescu A; Fermin Risso C; Cook AJ; Weber BA; Huynh M; Dave S; Parikh N; Lee L; Lorenzo A; Odeh R; Bowlin P; Traubici J; Koyle M; Dave S; Wang P; Romagnoli C; Fenster A; Bolduc S; Fortin A; Morin V; Gervais P; Daugherty MR; Bratslavsky G; Riddell J; Alyami F; Bowlin P; Lee L; Braga LH; Koyle M; Lorenzo A; Alyami F; Alqarni N; Odeh R; Penna FJ; Lee L; Dos Santos J; Koyle M; Lorenzo A; Farhat WA; Alyami F; Bowlin P; Lee L; Gleason JM; Braga LH; Bagli DJ; Koyle M; Lorenzo A; Alyami F; Odeh R; Heidari Bateni Z; Farhat WA; Koyle M; Nguyen LN; Rediger C; Leonard M; Guerra L; Wehbi E; Dorgalli C; Hidas G; McLorie G; McAleer I; Selby B; Pribish M; Khoury AE; Wehbi E; Dorgalli C; Hidas G; McLorie G; McAleer I; Selby B; Pribish M; Khoury AE; Wehbi E; Walia A; Dorgalli C; Hidas G; McLorie G; McAleer I; Selby B; Pribish M; Khoury AE; Alqarni N; Odeh R; Butt H; Alkahtani M; Konstant L; Pandergast L; D’Arpino T; Koyle M; Pelletier J; Bolduc S; Moore K; Wilkes CG; Thibodeau BA; Metcalfe PD; Baltazar JAJ; D’Cruz J; Kim S; Rickard M; DeMaria JE; Braga LH; Penna FJ; Odeh R; Butt H; Lorenzo A; Farhat WA; Bagli DJ; Koyle M; Lee L; Gleason JM; Bowlin P; Alyami F; Penna FJ; Braga LH; Lorenzo A; Lobb I; Liu W; Carter D; Haig A; Lan Z; Sener A; Anderson P; McAlister VC; Sener A; Luke PP; Penna FJ; Lorenzo A; Butt H; Farhat WA; Koyle M; Lee L; Penna FJ; Harvey E; John P; Armstrong D; Luginbuehl I; Alyami F; Koyle M; Lorenzo A; Odeh R; Levine M; Schuler TD; Gourishankar S; Odeh R; Lorenzo A; Farhat WA; Alyami F; Jain A; Penna FJ; Butt H; Alqarni N; Koyle M; Gardiner C; Koulack J; McGregor TB; Rickard M; Brownrigg N; D’Cruz J; DeMaria JE; Braga LH; Luz MA; Mattana J; Ribeiro R; Luz MA; Mattana J; Ribeiro R; Alyami F; Bowlin P; Lee L; Farhat WA; Quirouet A; Abraham N; Goldman H; Shahrour W; Hunter CB; Suranah S; Batra V; Joshi PM; Kulkarni J; Sansalone S; Lazzeri M; Barbagli G; Kulkarni S; Almarzouq AN; Al-Yousef RJ; Aldousari S; Shahrour W; Joshi P; Hunter CB; Batra V; Suranah S; Kulkarni J; Kulkarni S, 2015, '2015 CUA Abstracts', Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 9, pp. S13 - S134

Benidir T; Finelli A; Hamilton R; Hersey K; Joshua A; Kulkarni G; Zlotta A; Fleshner N, 2015, 'MP73-02 PATIENT UNDERSTANDING REGARDING END-OF-LIFE PROSTATE CANCER AND PERSPECTIVES REGARDING COST/BENEFIT OF CURRENT TREATMENT PARADIGMS', Journal of Urology, 193, http://dx.doi.org/10.1016/j.juro.2015.02.2678

Azad AA; Leibowitz-Amit R; Eigl BJ; Lester R; Wells JC; Murray RN; Kollmannsberger C; Heng DYC; Joshua AM; Chi KN, 2014, 'A retrospective, Canadian multi-center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration-resistant prostate cancer', Prostate, 74, pp. 1544 - 1550, http://dx.doi.org/10.1002/pros.22872

Robert C; Ribas A; Wolchok JD; Hodi FS; Hamid O; Kefford R; Weber JS; Joshua AM; Hwu WJ; Gangadhar TC; Patnaik A; Dronca R; Zarour H; Joseph RW; Boasberg P; Chmielowski B; Mateus C; Postow MA; Gergich K; Elassaiss-Schaap J; Li XN; Iannone R; Ebbinghaus SW; Kang SP; Daud A, 2014, 'Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trial', The Lancet, 384, pp. 1109 - 1117, http://dx.doi.org/10.1016/S0140-6736(14)60958-2

Lebowitz-Amit R; Mete O; Asa SL; Ezzat S; Joshua AM, 2014, 'Malignant pheochromocytoma secreting vasoactive intestinal peptide and response to sunitinib: A case report and literature review', Endocrine Practice, 20, http://dx.doi.org/10.4158/EP14093.CR

Leibowitz-Amit R; Seah JA; Atenafu EG; Templeton AJ; Vera-Badillo FE; Alimohamed N; Knox JJ; Tannock IF; Sridhar SS; Joshua AM, 2014, 'Abiraterone acetate in metastatic castration-resistant prostate cancer: A retrospective review of the Princess Margaret experience of (I) low dose abiraterone and (II) prior ketoconazole', European Journal of Cancer, http://dx.doi.org/10.1016/j.ejca.2014.06.004

Gedye C; Hogg D; Butler M; Joshua AM, 2014, 'New treatments for metastatic melanoma', CMAJ. Canadian Medical Association Journal, 186, pp. 754 - 760, http://dx.doi.org/10.1503/cmaj.130989

Carvajal RD; Sosman JA; Quevedo JF; Milhem MM; Joshua AM; Kudchadkar RR; Linette GP; Gajewski TF; Lutzky J; Lawson DH; Lao CD; Flynn PJ; Albertini MR; Sato T; Lewis K; Doyle A; Ancell K; Panageas KS; Bluth M; Hedvat C; Erinjeri J; Ambrosini G; Marr B; Abramson DH; Dickson MA; Wolchok JD; Chapman PB; Schwartz GK, 2014, 'Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: A randomized clinical trial', JAMA, 311, pp. 2397 - 2405, http://dx.doi.org/10.1001/jama.2014.6096

Ribas A; Hodi FS; Kefford R; Hamid O; Daud A; Wolchok JD; Hwu W-J; Gangadhar TC; Patnaik A; Joshua AM; Hersey P; Weber JS; Dronca RS; Zarour HM; Gergich K; Li XN; Iannone R; Kang SP; Ebbinghaus S; Robert C, 2014, 'Efficacy and safety of the anti-PD-1 monoclonal antibody MK-3475 in 411 patients (pts) with melanoma (MEL).', Journal of Clinical Oncology, 32, pp. LBA9000 - LBA9000, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.lba9000

Joshua AM; Zannella VE; Downes MR; Bowes B; Hersey K; Koritzinsky M; Schwab M; Hofmann U; Evans A; Van Der Kwast T; Trachtenberg J; Finelli A; Fleshner N; Sweet J; Pollak M, 2014, 'A pilot 'window of opportunity' neoadjuvant study of metformin in localised prostate cancer', Prostate Cancer and Prostatic Diseases, 17, pp. 252 - 258, http://dx.doi.org/10.1038/pcan.2014.20

Leibowitz-Amit R; Templeton AJ; Omlin A; Pezaro C; Atenafu EG; Keizman D; Vera-Badillo F; Seah JA; Attard G; Knox JJ; Sridhar SS; Tannock IF; De Bono JS; Joshua AM, 2014, 'Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer', Annals of Oncology, 25, pp. 657 - 662, http://dx.doi.org/10.1093/annonc/mdt581

Beer TM; Armstrong AJ; Rathkopf DE; Loriot Y; Sternberg CN; Higano CS; Iversen P; Bhattacharya S; Carles J; Chowdhury S; Davis ID; De Bono JS; Evans CP; Fizazi K; Joshua AM; Kim CS; Kimura G; Mainwaring P; Mansbach H; Miller K; Noonberg SB; Perabo F; Phung D; Saad F; Scher HI; Taplin ME; Venner PM; Tombal B, 2014, 'Enzalutamide in metastatic prostate cancer before chemotherapy', New England Journal of Medicine, 371, pp. 424 - 433, http://dx.doi.org/10.1056/NEJMoa1405095

Leibowitz-Amit R; Alimohamed N; Vera-Badillo FE; Seah JA; Templeton AJ; Knox JJ; Tannock IF; Sridhar SS; Joshua AM, 2014, 'Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone', Prostate, 74, pp. 1462 - 1464, http://dx.doi.org/10.1002/pros.22861

Puts M; Krzyzanowska M; Amir E; Joshua A; Monette J; Wan-Chow-Wah D; Jang R; Alibhai S, 2014, 'A feasibility trial of geriatric assessment and management for older cancer patients', Journal of Geriatric Oncology, 5, pp. S47 - S48, http://dx.doi.org/10.1016/j.jgo.2014.09.080

Khoja LT; Nguyen L; Wang L; Zhang B; Nie J; Yen PH; Pnaik M; Powis M; Franke N; Crump M; Hogg D; Joshua AM; Ohashie P; Butler MO, 2014, 'A Phase Ii Study (Nct01883323) Evaluating the Infusion of Autologous Tumor-Infiltrating Lymphocytes (Til) and Low-Dose Interleukin-2 (Il-2) Therapy Following Non-Myeloablative Lymphodepletion Using Cyclophosphamide and Fludarabine in Patients with Metastatic Melanoma', Annals of Oncology, 25, pp. iv391 - iv391, http://dx.doi.org/10.1093/annonc/mdu344.44

Hansen A; Geddie W; Boerner S; Ghai S; Berman H; Serra S; Roehrl M; Joshua AM; Oza AM; Moore M; Amir E; Usmani T; Giesler A; Amin N; Zhang T; Sukhai M; Stockley T; Kamel-Reid S; Siu LL; Bedard P, 2014, 'Fine Needle Biopsies are Feasible As a Minimally Invasive Means for Targeted Next Generation Sequencing in Advanced Solid Tumors', Annals of Oncology, 25, pp. iv558 - iv558, http://dx.doi.org/10.1093/annonc/mdu358.43

Bochner B; Sperling D; Feifer A; Mashni J; Bajorin D; Dalbagni G; Herr H; Donat SM; Milowsky M; Shah J; Kamat A; Grossman HB; Grubb R; Brandes S; Bullock A; Strope S; Roth B; Kibel A; Weigand L; Steinberg G; Stadler W; Rutiaga N; Schoenberg M; Bivalacqua T; Rogers C; Black P; So A; Gleave M; Kassouf W; Bachir B; Yafi F; Lerner S; Godoy G; Amiel G; Zlotta A; Fleshner N; Jewett M; Kulkarni G; Sridhar S; Tanock I; Joshua A; Bostrom P; Kuk C; Lotan Y, 2014, 'MP60-12 MULTI-INSTITUTIONAL QUALITY CARE INITIATIVE TO IMPROVE THE CARE OF PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER', Journal of Urology, 191, http://dx.doi.org/10.1016/j.juro.2014.02.1766

Hodi FS; Ribas A; Daud A; Hamid O; Robert C; Kefford R; Hwu W-J; Gangadhar TC; Joshua AM; Hersey P; Weber J; Joseph RW; Zarour H; Dronca R; Gammage L; Hille D; Xue D; Kang SP; Chun P; Ebbinghaus SW; Perrone A; Wolchok JD, 2014, 'Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)', Journal for immunotherapy of cancer, 2, pp. P103 - P103, http://dx.doi.org/10.1186/2051-1426-2-s3-p103

Robert C; Mateus C; Hodi S; Kefford R; Hamid O; Daud A; Wolchok J-D; Hwu W-J; Gangadhar T-C; Patnaik A; Joshua A-M; Hersey P; Weber J; Dronca R; Zarour H; Gergich K; Li X-N; Lannone R; Kang S-P; Ebbinghaus S; Ribas A, 2014, 'Traitement par anticorps anti-PD-1 : pembrolizumab (MK-3475) chez 411 patients (pts) atteints de mélanome métastatique', Annales de Dermatologie et de Vénéréologie, 141, pp. S258 - S259, http://dx.doi.org/10.1016/j.annder.2014.09.084

Richter S; Ruether JD; Wood L; Canil C; Moretto P; Venner P; Gingerich J; Emmenegger U; Eisen A; Zalewski P; Joshua A; Mukherjee SD; Heng D; Czaykowski P; Soulieres D; Blais N; Rendon R; Fleshner N; Crook JM; Sridhar SS, 2013, 'Management of carcinoma of the penis: Consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO)', CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 7, pp. E797 - E811, http://dx.doi.org/10.5489/cuaj.1794

Pra AD; Lalonde E; Sykes J; Warde F; Ishkanian A; Meng A; Maloff C; Srigley J; Joshua AM; Petrovics G; Van Der Kwast T; Evans A; Milosevic M; Saad F; Collins C; Squire J; Lam W; Bismar TA; Boutros PC; Bristow RG, 2013, 'TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: Implications for fusion status anddsb repair', Clinical Cancer Research, 19, pp. 5202 - 5209, http://dx.doi.org/10.1158/1078-0432.CCR-13-1049

Leibowitz-Amit R; Joshua AM, 2013, 'The changing landscape in metastatic castration-resistant prostate cancer', Current Opinion in Supportive and Palliative Care, 7, pp. 243 - 248, http://dx.doi.org/10.1097/SPC.0b013e328362ffef

Hamid O; Robert C; Daud A; Hodi FS; Hwu WJ; Kefford R; Wolchok JD; Hersey P; Joseph RW; Weber JS; Dronca R; Gangadhar TC; Patnaik A; Zarour H; Joshua AM; Gergich K; Elassaiss-Schaap J; Algazi A; Mateus C; Boasberg P; Tumeh PC; Chmielowski B; Ebbinghaus SW; Li XN; Kang SP; Ribas A, 2013, 'Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma', New England Journal of Medicine, 369, pp. 134 - 144, http://dx.doi.org/10.1056/NEJMoa1305133

Carvajal RD; Sosman JA; Quevedo F; Milhem MM; Joshua AM; Kudchadkar RR; Linette GP; Gajewski T; Lutzky J; Lawson DH; Lao CD; Flynn PJ; Albertini MR; Sato T; Paucar D; Panageas KS; Dickson MA; Wolchok JD; Chapman PB; Schwartz GK, 2013, 'Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM).', Journal of Clinical Oncology, 31, pp. CRA9003 - CRA9003, http://dx.doi.org/10.1200/jco.2013.31.18_suppl.cra9003

Manokumar T; Aziz S; Rizvi F; Breunis H; Joshua AM; Tannock I; Alibhai SMH, 2013, 'A prospective study examining PROs and other geriatric outcomes in older adults with prostate cancer undergoing chemotherapy.', Journal of Clinical Oncology, 31, pp. 9555 - 9555, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.9555

Ribas A; Robert C; Daud A; Hodi FS; Wolchok JD; Kefford R; Patnaik A; Hwu W-J; Weber JS; Joshua A; Hersey P; Gangadhar TC; Joseph RW; Dronca RS; Zarour HM; Ebbinghaus S; Gergich K; Li XN; Kang SP; Hamid O, 2013, 'Clinical efficacy and safety of lambrolizumab (MK-3475, Anti-PD-1 monoclonal antibody) in patients with advanced melanoma.', Journal of Clinical Oncology, 31, pp. 9009 - 9009, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.9009

Joshua AM; Zannella VE; Downes MR; Bowes B; Koritzinsky M; Sweet J; Trachtenberg J; Jewett MAS; Finelli A; Fleshner NE; Pollak MN, 2013, 'Final results of a phase II study of neoadjuvant metformin in prostatic carcinoma.', Journal of Clinical Oncology, 31, pp. 5070 - 5070, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.5070

Margel D; Urbach DR; Lipscombe L; Bell C; Kilkarni G; Austin P; Joshua AM; Fleshner NE, 2013, 'Metformin use and all-cause and prostate-cancer-specific mortality among diabetic men.', Journal of Clinical Oncology, 31, pp. 5007 - 5007, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.5007

Hotte SJ; Eisenhauer EA; Joshua AM; Kumar V; Ellard S; Gregg RW; Macfarlane RJ; Winquist E; Torri V; Ruether JD; Basappa NS; Kakumanu AS; North SA; Kollmannsberger CK; Tinker A; Mirchandani D; Tassignon A; Hausman DF; Allan AL; Chi KN, 2013, 'NCIC CTG, IND-205: A phase II study of PX-866 in patients with recurrent or metastatic castration-resistant prostate cancer (CRPC).', Journal of Clinical Oncology, 31, pp. 5042 - 5042, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.5042

Leibowitz-Amit R; Templeton AJ; Atenafu EG; Vera-Badillo FE; Chllamma M; Solow HL; Knox JJ; Tannock I; Sridhar SS; Joshua AM, 2013, 'Novel predictive markers of PSA response to abiraterone acetate in men with metastatic castration-resistant-prostate-cancer (mCRPC).', Journal of Clinical Oncology, 31, pp. 5058 - 5058, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.5058

Carvajal RD; Sosman JA; Quevedo F; Milhem MM; Joshua AM; Kudchadkar RR; Linette GP; Gajewski T; Lutzky J; Lawson DH; Lao CD; Flynn PJ; Albertini MR; Sato T; Paucar D; Panageas KS; Dickson MA; Wolchok JD; Chapman PB; Schwartz GK, 2013, 'Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM).', Journal of Clinical Oncology, 31, pp. CRA9003 - CRA9003, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.cra9003

Authors V, 2013, 'Abstracts from the 33rd Annual Scientific Meeting of the Canadian Geriatrics Society Toronto, April 2013', Canadian Geriatrics Journal, 16, pp. 66 - 103, http://dx.doi.org/10.5770/cgj.16.85

Yoshimoto M; Ding K; Sweet JM; Ludkovski O; Trottier G; Song KS; Joshua AM; Fleshner NE; Squire JA; Evans AJ, 2013, 'PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade', Modern Pathology, 26, pp. 435 - 447, http://dx.doi.org/10.1038/modpathol.2012.162

Niraula S; Pond G; de Wit R; Eisenberger M; Tannock IF; Joshua AM, 2013, 'Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study', Journal of the Canadian Urological Association, 7, http://dx.doi.org/10.5489/cuaj.267

Templeton AJ; Vera-Badillo FE; Wang L; Attalla M; De Gouveia P; Leibowitz-Amit R; Knox JJ; Moore M; Sridhar SS; Joshua AM; Pond GR; Amir E; Tannock IF, 2013, 'Translating clinical trials to clinical practice: Outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials', Annals of Oncology, 24, pp. 2972 - 2977, http://dx.doi.org/10.1093/annonc/mdt397

Lun G; Atenafu EG; Knox JJ; Sridhar SS; Tannock IF; Joshua AM, 2013, 'Use of a clinical assistant to screen patients with genitourinary cancer to encourage entry into clinical trials and use of supportive medication: A pilot project at a canadian cancer center', Clinical Genitourinary Cancer, 11, http://dx.doi.org/10.1016/j.clgc.2013.04.008

Ryan C; Smith M; de Bono J; Molina A; Logothetis D; De Souza P; et A, 2013, 'Abiraterone in metastatic prostate cancer without previous chemotherapy', New England Journal of Medicine, 368, pp. 138 - 148, http://dx.doi.org/10.1056/NEJMoa1209096

Nguyen LT; Butler MO; Yen PH; Nie J; Pniak M; Elford AR; Joshua AM; Hogg D; Ghazarian D; Al-Habeeb A; Easson AM; Leong WL; McCready DR; Reedijk M; Messner HA; Ohashi PS, 2013, 'Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy', Journal for immunotherapy of cancer, 1, pp. P25 - P25, http://dx.doi.org/10.1186/2051-1426-1-s1-p25

Back to profile page